AIM: To evaluate the incidence of late biliary complications in non-resectable alveolar echinococcosis (AE) under long-term chemotherapy with benzimidazoles.
基金Supported by The Foundation for Medical Research and Development(Winterthur,Switzerland),the Gebert-Ruef Foundation(Zurich,Switzerland)the Baugarten-Foundation(Zurich,Switzerland)+3 种基金the OPO-Foundation(Zurich,Switzerland)the Caritative Foundation Gerberten Bosch(Zurich Switzerland)the UBS(Zurich,Switzerland)acting on behalf of a major anonymous sponsorandSwiss National Science Foundation Grants NO.320000-114009/3 and NO.32473B_135694/1(Vavricka SR)
文摘AIM: To evaluate the incidence of late biliary complications in non-resectable alveolar echinococcosis (AE) under long-term chemotherapy with benzimidazoles.
